Genmab EBIT 2019-2024 | GMAB
- Genmab 2023 EBIT was 0.773B, a 14.17% decline from 2022.
- Genmab 2022 EBIT was 0.9B, a 87.47% increase from 2021.
- Genmab 2021 EBIT was 0.48B, a 50.35% decline from 2020.
EBIT can be defined as earnings before interest and taxes.